We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ARCATUS (Arctic Vision Australia Pty Ltd)
Product name
ARCATUS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
252 (255 working days)
Active ingredients
triamcinolone acetonide
Registration type
EOI
Indication
ARCATUS® is indicated for the treatment of macular oedema associated with noninfectious uveitis.